2009-07-29 - More than 45 customers learned about PAT implementation, ROI and new technologies
Raleigh, North Carolina, July 29, 2009 – ABB and NNE Pharmaplan recently hosted a seminar that focused on the practical use and benefits of Process Analytical Technology (PAT) for Life Science manufacturers. More than 45 customers from 20 pharmaceutical/biotechnology companies participated in the half day event, held last month at the North Carolina Biotechnology Center campus in Research Triangle Park.
NNE Pharmaplan is an engineering and consulting company that focuses exclusively on the pharmaceutical and biotech industries; the company helps its clients plan and execute state-of-the-art facilities that meet all production and regulatory demands.
ABB has established expertise and has been at the forefront of developing solutions and standards for the implementation of PAT, including its next generation Industrial IT eXtended PAT (xPAT) solution, released earlier this year.
As a leading-edge quality control concept in the Life Sciences industries, PAT promotes the integration of analytical measurements into the manufacturing process to streamline and improve new product development, as well as improve the quality and ensure the safety of the end product.
ABB and NNE Pharmaplan combined their collective expertise to help the customers attending understand how their facilities could implement and benefit from PAT, as well as its positive impact on the bottom line.
“ABB is committed helping our customers and the industry understand how they can best leverage next generation technologies to help them improve their overall process and product quality,” said Dennis McKinley, ABB Life Sciences industry sales manager. “At the end of this seminar, when we asked participants if this session had met their goals for attending, every hand in the room went up!”
ABB provides the Life Science industries with a comprehensive range of leading-edge technologies, solutions and services that improve the efficiency, quality and safety of pharmaceutical development and manufacturing processes. In addition to PAT and integrated control and automation systems, these solutions include electrification, instrumentation, drives, robotics, batch process control systems, and collaborative production management (CPM) products and services. Learn more at www.abb.com/lifesciences.
ABB (www.abb.com) is a leader in power and automation technologies that enable utility and industry customers to improve performance while lowering environmental impact. The ABB Group of companies operates in around 100 countries and employs about 120,000 people. The company's North American operations, headquartered in Cary, North Carolina, employ about 12,000 people in 20 manufacturing and other major facilities.